Skip to search formSkip to main contentSkip to account menu

fowlpox-NY-ESO-1 vaccine

Known as: rF-NY-ESO-1 
A cancer vaccine consisting of a recombinant fowlpox virus vector encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1, an… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Vaccination strategies based on repeated injections of NY‐ESO‐1 protein formulated in ISCOMATRIX particles (NY‐ESO‐1 ISCOMATRIX… 
2013
2013
During cancer progression, malignant cells may evade immunosurveillance. However, evidence for immunological escape in humans is… 
Highly Cited
2012
Highly Cited
2012
Recombinant poxviruses (vaccinia and fowlpox) expressing tumor-associated antigens are currently being evaluated in clinical… 
2004
2004
Study design Eligible patients (pts) for the first part of the study were HLA-A2+ with advanced NY-ESO-1/LAGE+ tumors assessed by…